These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9724937)

  • 21. Selection of initial treatment for bipolar disorder, manic phase.
    Frye MA; Altshuler LL
    Mod Probl Pharmacopsychiatry; 1997; 25():88-113. PubMed ID: 9344372
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reversible neuropsychiatric side effects of lithium with normal serum levels. A case report].
    Fallgatter AJ; Strik WK
    Nervenarzt; 1997 Jul; 68(7):586-90. PubMed ID: 9333721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypernatremia as a rare complication in change from lithium to valproate].
    Berendes K; Glass W; Warmke C
    Nervenarzt; 2001 Jul; 72(7):555-7. PubMed ID: 11478229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment.
    Manto MU; Jacquy J; Hildebrand J
    Acta Neurol Belg; 1996 Dec; 96(4):316-7. PubMed ID: 9008782
    [No Abstract]   [Full Text] [Related]  

  • 25. Lithium intoxication, hypercalcemia and "accidentally" induced food and water aversion: a case report.
    Bilanakis N; Gibiriti M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):201-3. PubMed ID: 14687875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of the side-effect profiles of daily versus alternate-day dosing schedules in lithium maintenance treatment of manic-depressive disorder.
    Jensen HV; Davidsen K; Toftegaard L; Mellerup ET; Plenge P; Aggernaes H; Bjørum N
    J Affect Disord; 1996 Jan; 36(3-4):89-93. PubMed ID: 8821311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood stabilizers and treatment adherence in bipolar disorder: addressing adverse events.
    Berk M; Berk L
    Ann Clin Psychiatry; 2003; 15(3-4):217-24. PubMed ID: 14971867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Priapism associated with oxcarbazepine, aripiprazole, and lithium.
    Negin B; Murphy TK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223-4. PubMed ID: 16292111
    [No Abstract]   [Full Text] [Related]  

  • 31. Photophobia and lithium.
    Pridmore S; Powell G; Wise G
    Aust N Z J Psychiatry; 1996 Apr; 30(2):287-9. PubMed ID: 8811274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.
    Malhi GS; Tanious M
    CNS Drugs; 2011 Apr; 25(4):289-98. PubMed ID: 21425882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trade-off between the benefits of lithium treatment and the risk of chronic kidney disease.
    Adam WR; Schweitzer I; Walker RG
    Nephrology (Carlton); 2012 Nov; 17(8):776-9. PubMed ID: 23107125
    [No Abstract]   [Full Text] [Related]  

  • 34. Selection of the initial drug(s) in the treatment of bipolar disorder, depressed phase.
    Maj M
    Mod Probl Pharmacopsychiatry; 1997; 25():66-77. PubMed ID: 9344370
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
    Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
    J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium-induced kidney problems. Serious problems are unusual, but monitoring is key.
    Harv Ment Health Lett; 2009 Oct; 26(4):6-7. PubMed ID: 19904835
    [No Abstract]   [Full Text] [Related]  

  • 37. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
    Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
    Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Royal Melbourne Hospital Lithium Clinic.
    Schweitzer I; Davies B; Burrows G; Branton L; Turecek LR; Tiller J
    Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S35-8. PubMed ID: 10622178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium toxicity precipitated by thyrotoxicosis due to silent thyroiditis: cardiac arrest, quadriplegia, and coma.
    Sato Y; Taki K; Honda Y; Takahashi S; Yoshimura A
    Thyroid; 2013 Jun; 23(6):766-70. PubMed ID: 23206122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    Maina G; Albert U; Salvi V; Mancini M; Bogetto F
    J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.